Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P T Masiakos

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Seminars in Pediatric Surgery|August 1, 1997
Masculinizing and feminizing syndromes caused by functioning tumorsP T Masiakos, C E Flynn, P K Donahoe
Journal of Pediatric Surgery|August 2, 2001
Tracheal resection and reanastomosis in the neonatal periodS Islam, P T Masiakos, D P Doody, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 13, 1999
Extracorporeal membrane oxygenation for nonneonatal acute respiratory failureP T Masiakos, S Islam, D P Doody, et al.
Biochemistry|August 27, 1991
31P NMR saturation-transfer study of the in situ kinetics of the mitochondrial adenine nucleotide translocaseP T Masiakos, G D Williams, D A Berkich, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivoA E Stephen, P T Masiakos, D L Segev, et al.
The Journal of Biological Chemistry|January 5, 1991
Rates of various reactions catalyzed by ATP synthase as related to the mechanism of ATP synthesisD A Berkich, G D Williams, P T Masiakos, et al.
Endocrinology|May 26, 1999
Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cellsM M Lee, C C Seah, P T Masiakos, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|July 24, 2012
Behavior of poly(glycerol sebacate) plugs in chronic tympanic membrane perforationsC A Sundback, J McFadden, A Hart, et al.
The Journal of Biological Chemistry|August 26, 2000
Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanismT U Ha, D L Segev, D Barbie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MISP T Masiakos, D T MacLaughlin, S Maheswaran, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Seminars in Pediatric Surgery|August 1, 1997
Masculinizing and feminizing syndromes caused by functioning tumorsP T Masiakos, C E Flynn, P K Donahoe
Journal of Pediatric Surgery|August 2, 2001
Tracheal resection and reanastomosis in the neonatal periodS Islam, P T Masiakos, D P Doody, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 13, 1999
Extracorporeal membrane oxygenation for nonneonatal acute respiratory failureP T Masiakos, S Islam, D P Doody, et al.
Biochemistry|August 27, 1991
31P NMR saturation-transfer study of the in situ kinetics of the mitochondrial adenine nucleotide translocaseP T Masiakos, G D Williams, D A Berkich, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivoA E Stephen, P T Masiakos, D L Segev, et al.
The Journal of Biological Chemistry|January 5, 1991
Rates of various reactions catalyzed by ATP synthase as related to the mechanism of ATP synthesisD A Berkich, G D Williams, P T Masiakos, et al.
Endocrinology|May 26, 1999
Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cellsM M Lee, C C Seah, P T Masiakos, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|July 24, 2012
Behavior of poly(glycerol sebacate) plugs in chronic tympanic membrane perforationsC A Sundback, J McFadden, A Hart, et al.
The Journal of Biological Chemistry|August 26, 2000
Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanismT U Ha, D L Segev, D Barbie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MISP T Masiakos, D T MacLaughlin, S Maheswaran, et al.
Pageof 1